Plasma Growth Hormone Levels Research Articles

The Growth Hormone Affects the Brain Protein Synthesis Rate in Hypophysectomized Aged Rats

The purpose of this study was to determine whether the growth hormone (GH) affects the rate of brain protein synthesis in hypophysectomized aged rats. Experiments were conducted on three groups of 24-wk-old male rats: group 1 were hypophysectomized to reduce the level of plasma GH, group 2 were hypophysectomized and treated with GH and group 3 were sham-operated controls. The fractional rates of protein synthesis in the brains of hypophysectomized rats with GH were significantly greater than those in hypophysectomized rats without GH. In the cerebral cortex and cerebellum, the RNA activity [g protein synthesized/(g RNA.d)] significantly correlated with the fractional rate of protein synthesis (r>0.88, p<0.001). The RNA concentration (mg RNA/ g protein) was also related to the fractional rate of protein synthesis in these organs (r>0.56, p<0.05). The results suggest that the treatment of GH to hypophysectomized aged rats is likely to increase the rate of protein synthesis in the brain, and that RNA activity is at least partly related to the fractional rate of brain protein synthesis.

The effect of shearing procedures on blood levels of growth hormone, cortisol and other stress haematochemical parameters in Sarda sheep

The aim of this research was to investigate how growth hormone (GH) cortisol and some haematochemical parameters could be modified by the stress caused by the stages of shearing in Sarda breed sheep. Five groups of 10 sheep each were formed. Group A, only separated from the flock; Group B, only tied; Group C, both tied and shorn (animals in these three groups were ewe lambs shorn for the first time); Group D, adult females both tied and shorn; and Group E, adult entire males both tied and shorn (animals in these two groups had been shorn previously). Five blood samples were taken from each animal: the day before treatment (first sample); at the start of the treatment (second sample); in the middle of shearing for Groups C, D and E, 10 min after separation in Group A and 10 min after tying in Group B (third sample); at the end of treatment (fourth sample); and on the day after treatment (fifth sample). Plasma GH levels showed a decrease (P < 0.01) in Groups A, B, C and D during treatment (third and fourth samples), while Group E only at the end of shearing (fourth sample). In the third sample, the highest GH levels were recorded for Group E (P < 0.05), while it was recorded in the fourth sample for Groups A and E (P < 0.05). Cortisol levels showed a clear increase (P < 0.01) in all groups during treatment, but Group A showed a decrease in the fourth sample in comparison to the third sample. Males in the second, third and fourth sample and Group A only in the fourth sample showed lower cortisol levels when compared with the other groups (P < 0.05). Plasma glucose levels showed an increase (P < 0.01) in all groups during treatment but Groups B, C and E showed the highest values (P < 0.05). Magnesium (Mg) showed an increase in all groups in the third and fourth sample, while sodium (Na), in the same samples, only in Groups B, C and D. Potassium (K) values showed a significant decrease (P < 0.05) only in Groups C and D at the end of shearing. These results show that GH secretion is influenced by all the stress procedure: separation, tying and shearing. Shearing, even if necessary for animals, causes a significant change of the blood parameters involved in the stress response.

The neuroendocrine events during the ovine growth-promoted maturation: The developmental importance of hypophysiotrophic action of somatostatin in ewes

The comparison of hypothalamic somatostatin (SRIH)-neuronal systems, hypophyseal somatotroph populations and growth hormone (GH) blood plasma patterns among developmental stages, from infancy until puberty, may help to describe the nature of the hypothalamo-hypophyseal mechanisms underlying the changes in GH on the systemic level leading to the somatic, that is growth and sexual maturity in sheep. The aim of this study was to elucidate (i) developmental importance of hypophysiotrophic action of SRIH, (ii) precise time of maturation of this action and (iii) photoperiodic regulation of the postnatal ontogeny in ewes. The central and peripheral activity of the SRIH-GH axis is described through a sequence of histomorphological and functional changes in Merino ewes born after the summer solstice. The actual time of puberty of these animals was delayed until the following breeding season, when the sheep were 14-month old. Histomorphometric examinations have been made in 21 infantile (preweanling, 12-week old), prepubertal (15- and 22-week old), peripubertal (30- and 52-week old) and pubertal (63-week old) ovary-intact sheep. Functional examinations of the GH plasma levels were determined every 1–2 weeks during the period from the 12th to 63rd week of age. The highest GH level was observed at the 13th week of age, on the beginning of the breeding season. The fluctuations in the GH level just after the winter and summer solstice were detected as the one and only deviation from a rule of uniformly low GH concentrations observed until puberty. The age of the fall in serum GH levels corresponded with the postweaning period and the beginning of the phase of the lower daily live-weight gains (growth rate). Thus, the development of GH secretion was finished before the 15th week of age, that is together with the ending of the transitional infantile/prepubertal period, whereas the maturational processing within the hypothalamo-hypophyseal unit prolonged after the 15th week of age until 22 weeks of age and concerned the role of SRIH as the hypophysiotrophic factor regulating somatic maturation, i.e. attenuating growth. Altogether, the pattern of GH secretion during weaning is important for the shift between infancy and prepuberty depended upon an intensive growth and defined as growth maturation. The maturation of the SRIH-GH axis is finished by 22 weeks of age, independently of photoperiodic influences, whereas the neuroendocrine mechanisms to integrate somatic, that is growth and sexual maturation, are seasonal in nature in the ewe. Our observations confirm the hypothesis of the inherent endogenous rhythm controlling somatic maturation in the sheep.

Effects of Moderate Consumption of Distilled and Fermented Alcohol on Some Aspects of Neuroimmunomodulation

Alcoholic beverages are characterized by their fermented versus distilled origin and also by their degree of alcohol. The toxic effects of chronic alcohol consumption have been widely studied. However, there is less evidence about possible beneficial effects of moderate alcohol intake. This work was aimed at evaluating the effects of moderate alcohol consumption (beer or ethanol) on plasma hormone concentrations, blood and thymus lymphocyte phenotypes and brain neurotransmitter levels. For this purpose, 40 adult Wistar male rats were administered ethanol or beer for 4 weeks (experimental groups). Age-matched rats were administered beer without alcohol or water to be used as controls. Rats were killed by decapitation and plasma from the trunk blood was collected to measure plasma prolactin, growth hormone and ACTH concentrations by homologous specific double antibody radioimmunoassays. Thymus and blood lymphocyte subsets were measured by flow cytometry. Neurotransmitter concentrations [dopamine, γ-aminobutyric acid (GABA) and taurine] were measured by high pressure liquid chromatography in the median eminence and the pituitary. Blood and thymus lymphocyte subsets were not significantly changed by either ethanol or beer consumption, compared to controls. Plasma prolactin levels significantly decreased in ethanol-administered groups (p < 0.05) compared to control animals drinking water, although plasma levels of growth hormone and ACTH were not modified by either alcohol used. Dopamine and GABA concentrations in the median eminence or in the adenohypophysis remained unmodified by moderate beer or ethanol consumption. However, taurine concentration was significantly increased in the pituitary (p < 0.05) in the group drinking ethanol compared to those groups drinking beer with or without alcohol. These data suggest that moderate alcohol consumption may change the regulatory mechanism of prolactin secretion. Whether these modifications have a physiological significance deserves further research.

Effects of long-day on gill Na+, K+-ATPase gene expression and the development of seawater tolerance in sockeye salmon

Photoperiod is one of the major environmental cues that initiate smolting, but its mechanisms of action are not clear. We therefore examined possible effects of increased daylength on the development of seawater tolerance and gill Na+, K+-ATPase (NKA) in sockeye salmon (Oncorhynchus nerka). Seawater tolerance and related biological changes were assessed in terms of plasma sodium concentration after 24 h seawater challenge tests (plasma Na), gill NKA activity, expression of two isoform genes encoding gill NKA α subunits (α1a and α1b), and plasma levels of cortisol and growth hormone (GH). Juvenile fish transferred to an artificial long-day (16 h light/8 h dark cycle) in December showed lower plasma Na and higher gill NKA activity during winter than fish with held on a short-day (8 h light/16 h dark cycle). The amount of α1b mRNA in the long-day group was higher than that in the short-day group, whereas the amount of α1a mRNA in the long-day group was lower than that in the short-day group. Furthermore, the plasma levels of GH and cortisol in the long-day group increased earlier than in the short-day group. These results indicate that the increased daylength stimulates seawater tolerance, possibly through induction of the gill NKA α1b gene by elevated GH and cortisol.

Plasma growth hormone concentrations in female yak (Poephagus grunniens L.) of different ages:Relations with age and body weight

The role of growth hormone (GH) in postnatal growth is well established. Its basal level and relation to growth performance in different age group yaks has not been characterized until now. To estimate the normal blood GH level in yaks, a total of eighty five female yaks were divided in to thirteen age groups. BW of all animals was recorded on two consecutive days per week and average of weekly BW was considered for growth rate calculation. Blood samples collected twice weekly for four consecutive weeks were assayed for GH by a direct, simple and highly sensitive enzyme immunoassay (EIA) on microtitre plates using the biotin–streptavidin amplification system and the second antibody coating technique developed for the first time in this species. The EIA was carried out directly in 100 μL of yak plasma. The sensitivity of EIA procedure was 20 pg/well GH, which corresponds to 0.2 ng/mL plasma For the biological validation of assay, 2 mature yaks were administered (10 μg, iv) with a synthetic analogue of GHRH and blood samples were collected at 15-min interval using indwelling jugular catheter beginning 2 h prior to GHRH injection till 8 h thereafter. In both the animals, sharp increases in GH concentrations were recorded 75 min post GHRH administration, which confirms the biological validation of the EIA. It was found that mean GH among the age groups differ (p<0.05). With increasing age and BW, GH level decreased. The age groups with higher plasma GH showed higher growth rates (r=0.73). In conclusion, a highly sensitive enzymeimmunoassay procedure has been developed for the first time to determine plasma GH levels in bovine (yak) plasma. A close relationship of plasma GH concentration with age, BW and growth rates was found in yaks.

Ghrelin enhances the nocturnal secretion of cortisol and growth hormone in young females without influencing sleep

Ghrelin was shown to increase slow wave sleep (SWS) and the secretion of growth hormone (GH) and cortisol in young males. In terms of sleep, such information for females, however, is lacking. Therefore, polysomnographies were recorded (23:00-07:00 h) and nocturnal (20:00-07:00 h) secretion profiles of GH and cortisol were determined in 10 healthy females (24.9+/-2.4 years, body mass index: 21.2+/-1.1) twice, receiving four boluses of 50 microg ghrelin or placebo at 22:00, 23:00, 00:00, and 01:00 h, in this single-blind, randomized, cross-over study. No significant differences of conventionally or quantitatively analyzed sleep were observed between ghrelin and placebo condition. First administration of ghrelin caused a marked mean increase of GH by 53.3 to 64.4+/-14.2 ng/ml (placebo: 5.9+/-1.5 ng/ml) and cortisol by 54.2 to 96.4+/-15.3 ng/ml (placebo: 27.5+/-4.7 ng/ml). The following ghrelin injections were associated with smaller increases of GH and cortisol. In the ghrelin condition, GH plasma levels remained significantly (P<0.05) higher from 22:20 to 02:00 h and cortisol plasma levels from 22:20 to 02:20 h. In contrast to findings in young men, ghrelin did not affect sleep in young women, indicating a sexual dimorphism. In accordance with the findings in young men, ghrelin stimulated secretion of GH and cortisol.

Endocrine systems in juvenile anadromous and landlocked Atlantic salmon ( Salmo salar): Seasonal development and seawater acclimation

The present study compares developmental changes in plasma levels of growth hormone (GH), insulin-like growth factor I (IGF-I) and cortisol, and mRNA levels of their receptors and the prolactin receptor (PRLR) in the gill of anadromous and landlocked Atlantic salmon during the spring parr-smolt transformation (smoltification) period and following four days and one month seawater (SW) acclimation. Plasma GH and gill GH receptor (GHR) mRNA levels increased continuously during the spring smoltification period in the anadromous, but not in landlocked salmon. There were no differences in plasma IGF-I levels between strains, or any increase during smoltification. Gill IGF-I and IGF-I receptor (IGF-IR) mRNA levels increased in anadromous salmon during smoltification, with no changes observed in landlocked fish. Gill PRLR mRNA levels remained stable in both strains during spring. Plasma cortisol levels in anadromous salmon increased 5-fold in May and June, but not in landlocked salmon. Gill glucocorticoid receptor (GR) mRNA levels were elevated in both strains at the time of peak smoltification in anadromous salmon, while mineralocorticoid receptor (MR) mRNA levels remained stable. Only anadromous salmon showed an increase of gill 11β-hydroxysteroid dehydrogenase type-2 (11β-HSD2) mRNA levels in May. GH and gill GHR mRNA levels increased in both strains following four days of SW exposure in mid-May, whereas only the anadromous salmon displayed elevated plasma GH and GHR mRNA after one month in SW. Plasma IGF-I increased after four days in SW in both strains, decreasing in both strains after one month in SW. Gill IGF-I mRNA levels were only increased in landlocked salmon after 4 days in SW. Gill IGF-IR mRNA levels in SW did not differ from FW levels in either strain. Gill PRLR mRNA did not change after four days of SW exposure, and decreased in both strains after one month in SW. Plasma cortisol levels did not change following SW exposure in either strain. Gill GR, 11β-HSD2 and MR mRNA levels increased after four days in SW in both strains, whereas only the anadromous strain maintained elevated gill GR and 11β-HSD2 mRNA levels after one month in SW. The results indicate that hormones and receptors of the GH and cortisol axes are present at significantly lower levels during spring development and SW acclimation in landlocked relative to anadromous salmon. These findings suggest that attenuation of GH and cortisol axes may, at least partially, result in reduced preparatory upregulation of key gill ion-secretory proteins, possibly a result of reduced selection pressure for marine adaptations in landlocked salmon.

The PPAR-Gamma Activator Rosiglitazone Fails to Lower Plasma Growth Hormone and Insulin-Like Growth Factor-1 Levels in Patients with Acromegaly

Background/Aim: Despite combined therapy consisting of surgery, external X-ray, and medical therapy, a significant number of acromegaly patients continue to have uncontrolled growth hormone (GH) secretion and active disease. These patients, particularly those with large or invasive tumors, require additional therapy to decrease their GH levels. Our aim was to investigate whether patients with documented GH-secreting pituitary adenomas leading to acromegaly would respond with attenuation of GH and insulin-like growth factor-1 (IGF-1) levels after treatment with a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist. Methods: We conducted prospective analyses in the Endocrinology Clinic of the Pamukkale University. Acromegaly patients who had active disease participated in two admissions: before and after 6 weeks of daily treatment with 8 mg of oral rosiglitazone. Four male and 3 female patients have completed the study. Basal and nadir GH levels during an oral glucose tolerance test were determined, and the IGF-1 and IGF-binding protein-3 levels were also measured both before and 6 weeks after the rosiglitazone treatment. Results: Treatment with rosigitazone did not reduce basal and nadir GH levels during the oral glucose tolerance test and the IGF-1 levels in the patient population as a whole (p > 0.05). Conclusions: The PPAR-γ activator rosiglitazone, used at maximum approved dosage, did not reduce plasma GH and IGF-1 levels in patients with acromegaly. Further studies with higher doses and longer duration of PPAR-γ agonist administration would be required to determine its usefulness in the treatment in this group of patients.

Aqueous exposure to 4‐nonylphenol and 17β‐estradiol increases stress sensitivity and disrupts ion regulatory ability of juvenile Atlantic salmon

Population declines of wild Atlantic salmon have been attributed to an array of anthropogenic disturbances, including dams, commercial and recreational fishing, habitat loss, and pollution. Environmental contaminants in particular, can act as environmental stressors on fish, typically causing disruption of ion homeostasis due to their close association with the aquatic environment. To examine the effects of the xenoestrogen 4-nonylphenol (NP) or 17beta-estradiol (E2) on stress sensitivity and ion regulation, we exposed juvenile Atlantic salmon continuously for 21 d to either 10 or 100 microg/L NP (NP-L or NP-H), 2 microg/L E2 (positive control), or vehicle control during the parr-smolt transformation in April. After treatment, fish were sampled in freshwater (FW), transferred to 30 per thousand seawater (SW) for 24 h, or subjected to a handling stress. Estradiol and NP-H increased plasma vitellogenin in males and females, and E2 increased gonadosomatic index only in males. In FW, E2 reduced sodium potassium-activated adenosine triphosphatase activity as well as plasma levels of growth hormone, insulin-like growth factor I, and triiodothyronine. Both E2 and NP-H reduced plasma sodium in FW and increased plasma chloride in SW. Plasma cortisol levels pre- and poststressor were significantly elevated by all treatments relative to controls, but only E2 increased plasma glucose before and after the stressor. These results indicate that exposure of anadromous salmonids to environmental estrogens heightens sensitivity to external stressors, impairs ion regulation in both FW and SW, and disrupts endocrine pathways critical for smolt development.

Effects of hexazinone and atrazine on the physiology and endocrinology of smolt development in Atlantic salmon

Exposure to hexazinone (HEX) and atrazine (ATZ), highly mobile and widely used herbicides along rivers in the United States, is potentially harmful to Atlantic salmon, which have been listed as an endangered species. To determine the effects of these contaminants on smolt development, juvenile Atlantic salmon were exposed under flow-through conditions to 100 μg l −1 HEX, 10 and 100 μg l −1 ATZ in fresh water (FW) for 21 days at 10 °C beginning in mid-April. Twelve fish per treatment were sampled in FW, following a 24 h seawater (SW) challenge and after growth for 3 months in SW. Exposure to 100 μg l −1 HEX or 10 μg l −1 ATZ caused no mortalities of smolts in FW or after SW challenge, while 9% of the fish exposed to 100 μg l −1 ATZ died during exposure. Fish exposed to 100 μg l −1 ATZ reduced feeding after 10 days of exposure and had an impaired growth rate in FW and during the first month in SW; compensatory growth occurred in the second and third month in SW. HEX and ATZ at 10 μg l −1 exposure had no effect on plasma levels of cortisol, growth hormone (GH), insulin growth factor I (IGF-I), thyroxine (T 4) and plasma 3,5,3′-triiodo- l-thyronine (T 3), Cl −, Mg 2+, Na +, Ca 2+ in FW or after SW challenge. FW smolts exposed to 100 μg l −1 ATZ had decreased plasma Cl −, Mg 2+, Na + and Ca 2+ ions and increased cortisol. No effect on plasma levels of GH, IGF-I, T 4 or T 3 was found in FW smolts exposed to 100 μg l −1 ATZ. Following SW challenge, fish previously exposed to 100 μg l −1 ATZ had significant increases in hematocrit, plasma cortisol, Cl −, Mg 2+, Na +, Ca 2+ and a decrease in T 4 and T 3. It is concluded that under the conditions imposed in this study, HEX does not affect salinity tolerance of Atlantic salmon smolts, while ATZ causes ionoregulatory, growth and endocrine disturbance.

Induction of Three Vitellogenins by 17beta-Estradiol with Concurrent Inhibition of the Growth Hormone-Insulin-Like Growth Factor 1 Axis in a Euryhaline Teleost, the Tilapia (Oreochromis mossambicus)1

The objective of the present study was to utilize the male Mozambique tilapia (Oreochromis mossambicus) as a model for examining the molecular mechanisms that mediate the physiological transition between somatic and gonadal growth in female teleost fish, and in vertebrates in general. Partial cDNAs that encode multiple forms of vitellogenin (Vtg), which is the major precursor of yolk proteins, were cloned from estrogen-treated males and utilized to develop real-time quantitative RT-PCR assays, which were supplemented by an assay for Vtg immunoreactivity in the plasma. Alignment analyses of the amino acid sequences deduced from the vtg cDNAs revealed three distinct tilapia Vtgs, which were categorized as Aa-, Ab-, and C-type Vtgs. A single injection of male tilapias with 17beta-estradiol (E(2)) at 5 microg/g body weight significantly increased the plasma E(2) and hepatic levels of all three vtg transcripts within 1 day. Plasma E(2) levels declined after 3 days, whereas the plasma Vtg immunoreactivity and hepatic levels of the three vtg transcripts continued to increase. Hepatic expression of the estrogen receptor (esr) 1 gene, but not the esr2 gene, also increased markedly 1 day after E(2) injection and remained elevated for 5 days. While plasma growth hormone (Gh) levels were unaffected, hepatic expression of transcripts that encoded the Gh receptor and insulin-like growth factor 1 (Igf1) was suppressed by E(2), as were the plasma Igf1 levels. These results clearly suggest a distinct negative interplay between the growth and reproductive axes at the molecular level of key hepatic regulatory pathways involved in the control of energy utilization by gonadal and somatic growth processes.

Effect of fasting on young adults who have symptoms of hypoglycemia in the absence of frequent meals

Among otherwise healthy adults, there is a subgroup of individuals who develop symptoms of hypoglycemia during episodes of food restriction. The aim of the present study was to investigate whether such individuals develop hypoglycemia or react abnormally in other metabolic aspects during a 24-hour fast. Ninety medical students were asked if they wanted to participate. Sixteen were selected; none dropped out. A 24-hour fast was performed at a hospital ward. Blood samples and questionnaires were taken at eight specific times. During the fast, the sensitive group reported significantly higher scores on 'irritation' and 'shakiness'. However, no hypoglycemia occurred and the lowest detected blood glucose concentration was 3.7 mmol/l. There were no differences between the groups in plasma glucose, cortisol, growth hormone (GH), insulin, beta-hydroxybutyrate (beta-OH) and lactate levels. The blood pressures and heart rates were also similar. Adults, despite subjective signs of hypoglycemia, can fast without any metabolic or endocrine derangement.

Ghrelin Stimulates Growth Hormone Secretion and Food Intake in Aged Animals

Age-related decreases in energy expenditure have been associated with the loss of skeletal muscle and decline of food intake, possibly through a mechanism involving changes of growth hormone (GH) secretion and feeding behavior. Age-related declines of growth hormone secretion and food intake have been termed the somatopause and anorexia of ageing, respectively. Ghrelin, a 28-amino-acid peptide, was isolated from human and rat stomachs as an endogenous ligand of growth hormone secretagogue receptor. Ghrelin stimulates growth hormone release and food intake when peripherally administered to rodents and humans. PURPOSE: We investigate the relationship between age-related decline of growth hormone secretion and/or food intake and ghrelin function. METHODS: Male Long-Evans rats (4-week-old) were used. All rats were housed individually in plastic cages at constant room temperature and were given standard laboratory chow and water ad libitum. Experiments were conducted on rats at 3, 12, 24, and 27 months of age. Ghrelin (10 nmol/kg body weight) was administered intravenously to rats, after which GH concentrations and 2-hour food intake were measured. The plasma concentration of GH was determined with a Rat GH RIA kit. RESULTS: Body weight increased gradually in rats from 3- to 24-month of age. The body weight in 27-month-old rats was significantly decreased compared to 24-month-old rats. Food intake for 24 hours did not change from 3- to 24-month-old rats, while 24-hour food intake in 27-month-old rats was significantly decreased compared to 24-month-old rats. An intravenous administration of ghrelin to rats increased food intake in all generations. The amounts of ghrelin-induced food intake in 27-month-old rats were significantly decreased compared to the other generations. However, the ratio of ghrelin-induced food intake to 4-hr food intake was the same among the generations. In addition to orexigenic effect by ghrelin, intravenous administration of ghrelin elicited a marked increase in plasma GH levels, with the peak occurring 15 min after administration. CONCLUSIONS: Ghrelin replacement may improve physical abilities to stimulate GH secretion and feeding in aged animals. The present study will provide novel insights into the physiological function of ghrelin in ageing process.

Effects of Homologous Ghrelins on the Growth Hormone/Insulin-like Growth Factor-I Axis in the Tilapia, Oreochromis mossambicus

Ghrelin is a gut-brain peptide synthesized mainly in the oxyntic mucosal cells of the stomach, and has potent growth hormone (GH)-releasing and orexigenic activities. Recently, two forms of ghrelin, ghrelin-C8 and -C10, were identified in the Mozambique tilapia (Oreochromis mossambicus). The present study describes in vitro and in vivo effects of these endogenous ghrelins on the GH/insulin-like growth factor-I (IGF-I) axis. Ghrelin-C8 (100 nM) stimulated GH release from primary cultures of pituitary cells after 4 and 8 h of incubation, whereas no effect was seen on prolactin (PRL) release. Stimulatory effects of ghrelin-C8 and -C10 (100 nM) on GH release during 6 h of incubation were blocked by pre-incubation with GHS receptor antagonist, [D-Lys(3)]-GHRP-6 (10 microM). Intraperitoneal injection of ghrelin-C8 (1 ng/g body weight) and -C10 (0.1 and 1 ng/g body weight) significantly increased plasma GH levels after 5 h. Significant increases were observed also in hepatic expression of IGF-I and GH receptor (GHR) mRNA following injections of both forms of ghrelin (0.1 and 1 ng/g body weight), although there was no effect on plasma levels of IGF-I. In the next experiment, both forms of ghrelin (1 ng/g body weight) significantly increased plasma IGF-I levels 10 h after the injection. No significant effect of either ghrelin was observed on plasma PRL levels. Both forms of GHS receptor (GHSR-1a and -1b) were found in the pituitary, clearly indicating that tilapia ghrelins stimulate primarily GH release through the GHS receptor. Stimulation of hepatic expression of IGF-I and GHR suggests metabolic roles of ghrelin in tilapia.

Plasma ghrelin levels in rainbow trout in response to fasting, feeding and food composition, and effects of ghrelin on voluntary food intake

Ghrelin, a peptide hormone which stimulates growth hormone (GH) release, appetite and adiposity in mammals, was recently identified in fish. In this study, the roles of ghrelin in regulating food intake and the growth hormone (GH)-insulin-like growth factor I (IGF-I) system of rainbow trout (Oncorhynchus mykiss) were investigated in three experiments: 1) Pre- and postprandial plasma levels of ghrelin were measured in relation to dietary composition and food intake through dietary inclusion of radio-dense lead-glass beads, 2) the effect of a single intraperitoneal (i.p.) injection with rainbow trout ghrelin on short-term voluntary food intake was examined and 3) the effect of one to three weeks fasting on circulating ghrelin levels and the correlation with plasma GH and IGF-I levels, growth and lipid content in the liver and muscle was studied. There was no postprandial change in plasma ghrelin levels. Fish fed a normal-protein/high-lipid (31.4%) diet tended to have higher plasma ghrelin levels than those fed a high-protein/low-lipid (14.1%) diet. Plasma ghrelin levels decreased during fasting and correlated positively with specific growth rates, condition factor, liver and muscle lipid content, and negatively with plasma GH and IGF-I levels. An i.p. ghrelin injection did not affect food intake during 12-hours post-injection. It is concluded that ghrelin release in rainbow trout may be influenced by long-term energy status, and possibly by diet composition. Further, in rainbow trout, ghrelin seems to be linked to growth and metabolism, but does not seem to stimulate short-term appetite through a peripheral action.

Administration of ghrelin to young uraemic rats increases food intake transiently, stimulates growth hormone secretion and does not improve longitudinal growth

Ghrelin administration stimulates appetite and growth hormone (GH) secretion. Whether these effects are preserved in young individuals with chronic renal failure (CRF) and their potential benefit on growth is questioned. Three experiments were performed in subtotally nephrectomized young rats (Nx). (i) Food intake was monitored in CRF rats receiving saline intraperitoneally or a ghrelin dose (30 nmol) shown to increase food intake over 2 and 24 h in rats with normal renal function. (ii) Plasma levels of GH were measured after a dose of intravenous ghrelin (3 nmol) was given to three groups of five rats each: Nx, sham-operated fed ad libitum (SAL) and sham-operated pair-fed with Nx (SPF). (iii) Growth of Nx rats treated with intraperitoneal ghrelin (3 nmol) for 7 days (Nx-Ghr) was compared with that of SAL and Nx groups receiving saline (n=8-10 per group). In CRF rats, the dose of 30 nmol of ghrelin increased food consumption for 2 h (1.3+/-0.2 g vs 0.5+/-0.2 g, P<0.05) but not 24-h food intake (12.5+/-0.6 g vs 12.2+/-0.5 g). Ghrelin (3 nmol) increased plasma levels of GH, which were maximal 10 min after injection, no differences being observed among groups (SAL: 666.2+/-104.6 ng/ml; Nx: 691.6+/-90.7 ng/ml; SPF: 577.8+/-125.4 ng/ml). Return to basal GH levels was delayed in Nx. Ghrelin did not improve body length and weight gains, longitudinal bone growth rate or food intake in the Nx-Ghr group. In young uraemic rats, ghrelin increases appetite but not 24-h food intake, stimulates GH secretion and does not improve growth.

Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin

To assess the effects of the administration of exogenous ghrelin, a peptide with potent GH-releasing activity and glucose-enhancing and insulin-lowering properties, in obese patients with polycystic ovary syndrome (PCOS). Prospective, controlled study. Academic research environment. Twenty obese women with PCOS, and 15 obese controls. Oral glucose tolerance test (OGTT) and ghrelin test (1 microg/kg i.v. bolus). Basal hormonal assays, including ghrelin, were performed. Glucose, insulin, and C-peptide were assessed in a fasting condition and during the OGTT. Growth hormone, insulin, and glucose were measured basally and every 15 minutes for 90 minutes after the injection of ghrelin. Both groups showed an insulin response to the glucose load above the normal range. Significantly lower levels of ghrelin were detected in patients with PCOS compared to controls (108.96 +/- 27.65 Fmol/mL versus 162.47 +/- 42.23 Fmol/mL). Administration of ghrelin markedly enhanced GH levels in both groups (1,888.59 +/- 1,209.53 ng/mL and 1,639.95 +/- 631.79 ng/mL per 90 minutes as GH area under the curve, respectively), with a peak occurring 30 minutes after injection. Ghrelin also induced a trend toward an increase in plasma glucose levels, and a significant decrease in insulin concentrations in both groups. The injection of ghrelin seems to override the GH secretion defect in obese women with PCOS, and to induce glucoinsulinemic changes in both controls and obese patients with PCOS.

Influence of ration level on the growth performance and body composition of non-transgenic and growth-hormone-transgenic coho salmon ( Oncorhynchus kisutch)

Duplicate groups of size-matched (range in initial mean weight, 23.5–27.2 g) growth-hormone-transgenic (T; construct OnMTGH1) and non-transgenic (NT) juvenile coho salmon from wild (W) and commercial (COM) sources, were fed a high nutritive value steam pelleted dry diet by hand four times daily for 63 days to maximum ration (R) viz., T-R T, NT-W-R W, and NT-COM-R COM, or they were pair-fed the maximum ration ingested by NT-W fish (NT-COM-R W and T-R W) or that consumed by NT-COM fish (T-R COM). The pair-fed rations were below the maximum rations of NT-COM and T fish. All groups were provided with running (6–8 L/min), aerated (dissolved oxygen, 6.8–10.3 mg/L), 10.5–11.0 °C well water and a natural photoperiod during the study. T-R T coho had significantly higher growth rates (1.9 fold) and dry feed (2.2 fold) and digestible protein and energy intakes (1.7 fold) than noted for NT-W-R W and NT-COM-R COM fish. Moreover T-R T coho, unlike pair-fed T coho and all NT groups, did not show a body weight or seasonal decline in growth rate during the study. Feed and protein utilization, but not energy utilization, were enhanced significantly in T fish relative to NT-COM fish regardless of ration level. NT-W fish were not included in the two-way ANOVA of the performance results where genotype and ration level were the factors. Nevertheless, randomized block ANOVA of performance parameters for all treatment groups followed by Tukey's test with P = 0.05 indicated that NT-W-R W and NT-COM-R COM fish generally performed similarly. NT-W-R W, T-R W and T-R COM groups had lowest condition factors whereas those for NT-COM-R COM and NT-COM-R W were highest. Viscera-somatic indices were significantly enhanced in T fish relative to NT-COM fish (data analyzed by two-way ANOVA). Fish size-corrected terminal whole body proximate compositions were uninfluenced by treatment even though the initial moisture and lipid concentrations in T fish were respectively lower and higher than noted in NT fish. Fish mortality was uninfluenced by treatment. It is concluded that dramatic growth enhancement in T coho is mainly due to enhanced dietary intakes of protein and energy and to a small (∼ 17%) but nevertheless significant improvement in utilization of dietary protein for body protein synthesis. The latter occurred at high and reduced rations and may have been due to high and unregulated plasma growth hormone levels accompanied by increased titres of insulin-like growth factor (found elevated in this transgenic strain in other studies) and 3, 5, 3′ triiodo- l-thyronine. Collectively, these hormones likely directly stimulated tissue protein synthesis. Also, the former two hormones probably spared protein (amino acids) for growth by promoting fatty acid catabolism for energy. The latter effect, in turn, probably played a major role in appetite stimulation of T-R T fish while simultaneously protecting their tissues from excessive lipid deposition.

Developmental stage of Atlantic salmon parr regulates pituitary GH secretion and parr–smolt transformation

Atlantic salmon respond to increased photoperiod by elevation of plasma growth hormone (GH) levels during the period leading up to parr–smolt transformation, both under natural and farming conditions. The aim of the present study was to elucidate the ontogeny of this response, by exposing juvenile Atlantic salmon to increased daylength at different stages of development. Salmon fry were reared on 12 h light:12 h dark from first feeding and thereafter exposed to continuous light from a mean fork length of 5 cm (LL5) or 8 cm (LL8). Plasma GH increased in smolting individuals in the LL8 group, whereas in the LL5 group as well as in parr of the LL8 group, plasma GH levels remained low. Growth rate in length increased significantly in both groups in response to increase in daylength. Plasma IGF-I varied to a lesser degree, although in late July, the LL5 IGF-I levels exceeded those of the LL8 IGF-I levels. In the LL8 group, 33% of the fish smoltified 6 weeks after onset of continuous light, whereas all the fish in the LL5 group failed to smolt. At termination of the experiment, the incidence of precocious maturing males in the LL5 and LL8 group were 38% and 62%, respectively. In conclusion, based on the lack of a GH response in fish smaller than 8 cm, it is hypothesized that the development of a functional light-pituitary axis leading to an increase in plasma GH levels, sets the threshold developmental stage for successful parr–smolt transformation of Atlantic salmon.